Scripts Xanax XR 250tabs bottle

Scripts Xanax XR 250tabs bottle

This prescription for Xanax XR (Alprazolam Extended-Release) 1mg is written with specific, clinically appropriate parameters. The “XR” formulation is designed to release the medication slowly throughout the day, providing a stable, sustained anxiolytic effect rather than the immediate, short-lived relief of the immediate-release version. This makes it suitable for managing generalized anxiety disorder (GAD) where constant symptom control is needed.

Scripts Xanax XR 250tabs bottle

The quantity of 30 tablets with zero refills is a critical safety measure. Alprazolam is a Schedule IV controlled substance due to its potential for dependence, tolerance, and abuse. Limiting the supply to a one-month duration mandates a follow-up appointment before a new script can be issued. This allows the prescriber to assess the drug’s effectiveness, monitor for side effects like sedation or cognitive impairment, evaluate for any signs of misuse, and determine if continued therapy is necessary. This practice aligns with the standard of care for prescribing benzodiazepines.

Scripts Xanax XR 250tabs bottle

The instruction “No Substitution” (or “Dispense As Written”) is included to ensure the patient receives the brand-name Xanax XR and not a generic Alprazolam XR. While generics are typically bioequivalent, some patients may respond differently to various manufacturers due to subtle differences in the extended-release mechanism or inactive ingredients. For a medication with a narrow therapeutic index like alprazolam, ensuring consistency from month to month can be crucial for maintaining stable blood levels and preventing breakthrough anxiety or increased side effects. This directive guarantees the patient receives the exact product upon which the treatment plan was established Furthermore, combining this medication with other central nervous system depressants, such as opioids or alcohol, is strongly contraindicated due to the significant respiratory depression and fatal overdose. Patient education on these risks is a mandatory component of this prescription